Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis
May 24, 2024 07:07 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market Report by Drug class, Diabetes types, Route of Administration, Distribution Channels, Region and Company Analysis 2024-2032"...
Lipodystrophy - Market Insight, Epidemiology And Market Forecast 2023-2032: Robust Pipeline With Novel MOA and Oral ROA, Increasing Prevalence, and Effectiveness of Drugs Drives Market
February 22, 2023 08:08 ET
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Lipodystrophy - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This...
The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030
October 12, 2022 07:33 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Global Diabetes Drug Market Research Report 2022: Size, Forecasts, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis 2021-2027
May 04, 2022 04:23 ET
|
Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been...